HK1247961A1 - Crispr-cas component systems, methods and compositions for sequence manipulation - Google Patents

Crispr-cas component systems, methods and compositions for sequence manipulation

Info

Publication number
HK1247961A1
HK1247961A1 HK18107321.5A HK18107321A HK1247961A1 HK 1247961 A1 HK1247961 A1 HK 1247961A1 HK 18107321 A HK18107321 A HK 18107321A HK 1247961 A1 HK1247961 A1 HK 1247961A1
Authority
HK
Hong Kong
Prior art keywords
crispr
compositions
methods
component systems
sequence manipulation
Prior art date
Application number
HK18107321.5A
Other languages
Chinese (zh)
Inventor
Feng Zhang
David Olivier Bikard
Le Cong
David Benjamin Turitz Cox
Patrick Hsu
Wenyan Jiang
Shauiliang Lin
Luciano Marraffini
Randall Jeffrey Platt
Fei Ran
Neville Espi Sanjana
Original Assignee
Broad Inst Inc
Massachusetts Inst Technology
Harvard College
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broad Inst Inc, Massachusetts Inst Technology, Harvard College, Univ Rockefeller filed Critical Broad Inst Inc
Publication of HK1247961A1 publication Critical patent/HK1247961A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
HK18107321.5A 2012-12-12 2018-06-05 Crispr-cas component systems, methods and compositions for sequence manipulation HK1247961A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261736527P 2012-12-12 2012-12-12
US201361748427P 2013-01-02 2013-01-02
US201361757972P 2013-01-29 2013-01-29
US201361768959P 2013-02-25 2013-02-25
US201361791409P 2013-03-15 2013-03-15
US201361835931P 2013-06-17 2013-06-17

Publications (1)

Publication Number Publication Date
HK1247961A1 true HK1247961A1 (en) 2018-10-05

Family

ID=55306645

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15108120.9A HK1208045A1 (en) 2012-12-12 2015-08-21 Crispr-cas component systems, methods and compositions for sequence manipulation cas cas
HK18107321.5A HK1247961A1 (en) 2012-12-12 2018-06-05 Crispr-cas component systems, methods and compositions for sequence manipulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15108120.9A HK1208045A1 (en) 2012-12-12 2015-08-21 Crispr-cas component systems, methods and compositions for sequence manipulation cas cas

Country Status (4)

Country Link
DK (1) DK2825654T3 (en)
ES (3) ES2618531T3 (en)
HK (2) HK1208045A1 (en)
RU (1) RU2701662C9 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853829C (en) 2011-07-22 2023-09-26 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US20150166982A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
EP4269577A3 (en) 2015-10-23 2024-01-17 President and Fellows of Harvard College Nucleobase editors and uses thereof
SG11201900907YA (en) 2016-08-03 2019-02-27 Harvard College Adenosine nucleobase editors and uses thereof
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN110214180A (en) 2016-10-14 2019-09-06 哈佛大学的校长及成员们 The AAV of nucleobase editing machine is delivered
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
EP3592777A1 (en) 2017-03-10 2020-01-15 President and Fellows of Harvard College Cytosine to guanine base editor
CN110914426A (en) 2017-03-23 2020-03-24 哈佛大学的校长及成员们 Nucleobase editors comprising nucleic acid programmable DNA binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
JP2021500036A (en) 2017-10-16 2021-01-07 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. Use of adenosine base editing factors
BR112021018607A2 (en) 2019-03-19 2021-11-23 Massachusetts Inst Technology Methods and compositions for editing nucleotide sequences
CN116096873A (en) 2020-05-08 2023-05-09 布罗德研究所股份有限公司 Methods and compositions for editing two strands of a target double-stranded nucleotide sequence simultaneously

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534224B2 (en) * 2002-11-15 2017-01-03 Trustees Of Boston University Cis/trans riboregulators
AU2006282983B2 (en) * 2005-08-26 2012-08-02 Dupont Nutrition Biosciences Aps Use
US20100076057A1 (en) * 2008-09-23 2010-03-25 Northwestern University TARGET DNA INTERFERENCE WITH crRNA
US20140113376A1 (en) * 2011-06-01 2014-04-24 Rotem Sorek Compositions and methods for downregulating prokaryotic genes

Also Published As

Publication number Publication date
ES2635244T3 (en) 2017-10-03
RU2019127238A (en) 2019-09-20
RU2701662C2 (en) 2019-09-30
ES2618531T3 (en) 2017-06-21
RU2015128102A (en) 2018-12-21
RU2701662C9 (en) 2019-10-31
ES2861623T3 (en) 2021-10-06
RU2015128102A3 (en) 2018-12-21
HK1208045A1 (en) 2016-02-19
DK2825654T3 (en) 2017-08-21

Similar Documents

Publication Publication Date Title
HK1247961A1 (en) Crispr-cas component systems, methods and compositions for sequence manipulation
HK1208056A1 (en) Crispr-cas component systems, methods and compositions for sequence manipulation crispr-cas
HK1223645A1 (en) Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation crispr-cas
HK1216759A1 (en) Engineering of systems, methods and optimized guide compositions for sequence manipulation
EP2872641A4 (en) Biorefinery system, methods and compositions thereof
IL237625A0 (en) Anti-mcam antibodies, compositions comprising same and uses thereof
PL2896697T3 (en) Engineering of systems, methods and optimized guide compositions for sequence manipulation
IL238959A0 (en) Glutamase inhibitors, compositions comprising same and uses thereof
EP2920742A4 (en) Devices, systems, and methods for visual-attribute refinement
EP2827772A4 (en) Devices, systems, and methods for virtual staining
EP2897618A4 (en) Certain chemical entities, compositions, and methods
EP2827695A4 (en) Methods, devices, systems, and compositions for detecting gases
IL235004A0 (en) Anti-fgfr2 antibodies, compositions comprising same and uses thereof
GB2503131B (en) Systems, compositions and methods for transplantation
EP2916838A4 (en) Certain chemical entities, compositions, and methods
EP2806874A4 (en) Certain chemical entities, compositions, and methods
IL242795B (en) Compositions, methods, and devices for dialysis
IL233824A (en) 1h-indazole-3-carboxamide compounds, compositions comprising them and uses thereof
EP2852285A4 (en) Certain chemical entities, compositions, and methods
EP2868036A4 (en) Devices, systems, and methods for enriching communications
EP2892511A4 (en) Bolaamphiphilic compounds, compositions and uses thereof
IL237540A0 (en) Bolaamphiphilic compounds, compositions and uses thereof
HK1214862A1 (en) Cell-free biofragment compositions and related systems, devices, and methods
IL237538A0 (en) Bolaamphiphilic compounds, compositions and uses thereof
SG11201403809YA (en) Methods for software systems and software systems using the same